Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles

By Kishimoto Satoko   Ishihara Masayuki   Takikawa Megumi   Mori Yasutaka   Hattori Hidemi   Fujita Masanori   Nakamura Shingo  

Pharmaceutics, Vol. 4, Iss. 1, 2012-01 ,pp. : 42-57

MDPI

Access to resources Recommend Favorite

New Insights in Thrombin Inhibition Structure–Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin †

By Mourier Pierre A. J.   Guichard Olivier Y.   Herman Fréderic   Sizun Philippe   Viskov Christian  

Molecules, Vol. 22, Iss. 3, 2017-03 ,pp. : 428-428

MDPI

Access to resources Recommend Favorite

Low Molecular Weight Chitosan–Insulin Polyelectrolyte Complex: Characterization and Stability Studies

By Al-Kurdi Zakieh I.   Chowdhry Babur Z.   Leharne Stephen A.   Al Omari Mahmoud M. H.   Badwan Adnan A.  

Marine Drugs, Vol. 13, Iss. 4, 2015-03 ,pp. : 1765-1784

MDPI

Access to resources Recommend Favorite

Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin

By Mauri Lucio   Marinozzi Maria   Mazzini Giulia   Kolinski Richard E.   Karfunkle Michael   Keire David A.   Guerrini Marco  

Molecules, Vol. 22, Iss. 7, 2017-07 ,pp. : 1146-1146

MDPI

Access to resources Recommend Favorite

The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models

By Mueller Thomas   Pfankuchen Daniel Bastian   Wantoch von Rekowski Kathleen   Schlesinger Martin   Reipsch Franziska   Bendas Gerd  

Molecules, Vol. 22, Iss. 5, 2017-05 ,pp. : 728-728

MDPI

Access to resources Recommend Favorite